Immunization News and Research

RSS

arGEN-X BV announces first closing of its Series A equity financing round

arGEN-X BV, a biopharmaceutical company focused on the discovery and development of human antibodies using its proprietary SIMPLE Antibody platform, today announced the successful first closing of its Series A equity financing round. The Company raised EUR 9.5million (~ USD 13.6 million) from a syndicate of leading life science investors. The financing round is one of the largest of its kind in the last 12 months.

10 Sep 2009

Polio vaccination resumes in Pakistan's Swat Valley

"Authorities in Pakistan's Swat Valley have resumed vaccinating children for polio, an act once banned by Taliban militants, now beaten back by an army offensive," the Associated Press reports. The three-day campaign, which started on Monday, is targeting about 215,000 children, said government official Khurshid Khan.

10 Sep 2009

WHO's Chan says swine flu will 'test' world on 'fairness'

Addressing a meeting of South East Asian health ministers Tuesday, WHO Director-General Margaret Chan said the H1N1 (swine) flu pandemic will "test the world on the issue of fairness" and "reveal in a measurable and tragic way the consequences of decades of failure to invest adequately in basic health systems and infrastructure,"

10 Sep 2009

Roche Group and ImmunoCellular Therapeutics sign research agreement regarding ICT-69 antibody

ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC), a clinical-stage biotechnology company that is developing immune based therapies for the treatment of brain and other cancers, announced today that it has entered into a research and license option agreement regarding its ICT-69 antibody with Roche Group (SWX: ROG.VX; RO.S, OTCQX: RHHBY), one of the world’s leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics.

10 Sep 2009

E.V-Trax Employee Vaccination Tracking System helps eliminate manual data entry

General Data Company, Inc., which specializes in barcode-based error-proofing and tracking system solutions, is offering a new mobile application to help healthcare organizations administer employee vaccinations and track the immunization status of their personnel for H1N1, influenza, and other vaccinations.

10 Sep 2009

First trial of 2009 H1N1 influenza vaccine testing launched

The first trial testing a candidate 2009 H1N1 influenza vaccine in pregnant women is launching this week, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, announced today.

10 Sep 2009

Merck's GARDASIL receives approval from FDA Advisory Committee

Merck & Co., Inc. announced today that the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee agreed that efficacy, immunogenicity and safety data from clinical trials in males support the use of GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant] in boys and men 9 through 26 years of age for the prevention of genital warts caused by human papillomavirus (HPV) types 6 and 11.

10 Sep 2009

Maxim Health to launch its annual influenza vaccination program on October 1

It is the start of the flu season and with seasonal influenza responsible for more than 36,000 deaths per year, getting a flu vaccine is critical. Today, Maxim Health Systems announced on October 1 it will launch its annual influenza vaccination program and will provide flu shots nationwide through more than 44,000 clinics.

9 Sep 2009

Pharma manufacturer's failure to disclose endangers Swine Flu vaccination program

As autumn approaches and millions of Americans consider taking an H1N1 Swine Flu vaccination, the integrity of all vaccine developers has been called into question by the financial relationship of a leading vaccine advocate and a pharmaceutical manufacturer. Dr. Paul Offit of Children's Hospital of Philadelphia (CHOP), who was interviewed for a Dateline NBC television special, failed to tell millions of viewers that while he was promoting MMR as safe he had also made tens of millions of dollars from selling another vaccine patent to Merck, which is the manufacturer of MMR.

8 Sep 2009

Taskforce formed to help speed licensure, vaccine distribution following RTS,S trials

GNA/Peace FM examines the recent creation of a local and international taskforce to help shorten the window of time between the completion of the clinical trial of the RTS,S malaria vaccine - currently being tested across Africa - and licensure and vaccine distribution. According to the news service, scientists recently launched a Phase III trial of the RTS,S vaccine in Kintampo, Ghana, which will include 1,200 children, between the ages of 6-12 weeks and 5-17 months.

5 Sep 2009

rPA anthrax vaccine and its Valortim anthrax anti-toxin program data presented

PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, announced today that data from the Company's third generation recombinant protective antigen (rPA) anthrax vaccine program and its Valortim((R)) anthrax anti-toxin program were presented at the Bacillus - ACT 2009 meeting, August 30 - September 3, 2009, organized by the American Society for Microbiology.

4 Sep 2009

Department of Health's guidance on swine flu vaccination leaves local health chiefs confused

Thousands of frontline health workers in England are trapped in a postcode lottery after Department of Health (DH) guidance on swine flu vaccination has left local health chiefs confused over who is eligible for the jab.

4 Sep 2009

H1N1 vaccine to cost countries $2.50 - $20 per dose

The H1N1 (swine) flu vaccine will cost countries between $2.50 and $20 per dose, based on their ability to pay, according to the director of the Initiative for Vaccine Research at the WHO, Marie-Paule Kieny, Agence France-Presse/Khaleej Times reports. During an interview published in the September issue of the WHO Bulletin, Kieny "also warned that there would not be enough vaccines for the world's population and that people should not rely entirely on the vaccine," the news service writes (9/2).

3 Sep 2009

CDC recommends routine health examintion for all school-age children

Although school has just begun, it is already exam time for students throughout Wisconsin. That's because in addition to notebook paper and pens, back-to-school preparations should also include routine health exams to make sure students are healthy and ready to learn. These include: a doctor's exam to confirm that all immunizations are up-to-date, a dental exam and a vision exam.

3 Sep 2009

Obama urges Americans to take precautions to protect themselves from H1N1

After a day of meetings with senior White House officials to discuss the U.S. preparations for H1N1 (swine) flu Tuesday, President Obama urged Americans to take the proper precautions to protect themselves from infection, the Associated Press/Boston Herald reports (9/1).

3 Sep 2009

Members of Independence Blue Cross will receive coverage for the administration costs of the H1N1 vaccine

In an effort to help keep members healthy and flu-free this year, Independence Blue Cross (IBC) will offer coverage for the administration costs of the H1N1 (swine flu) vaccine when it becomes available. In addition IBC will continue to cover seasonal flu vaccine.

2 Sep 2009

HAPPYBABY guide for new and expectant parents focuses on green parenting

Green parenting -- more than just a trendy movement -- is the best way to raise healthy babies with lasting results. Parents today feel overwhelmed by all the choices and conflicting information when starting a family.

2 Sep 2009

Health care providers can register online for H1N1 influenza vaccines

Health care providers may now pre-register online if they are interested in receiving pandemic H1N1 influenza vaccines and supplies when those materials become available, the Pennsylvania Department of Health said today.

2 Sep 2009

Advertising campaign launched to encourage Americans practice healthy habits to prevent the spread of H1N1 flu

The Department of Health and Human Services, the Department of Homeland Security, the Department of Education and Sesame Workshop, the nonprofit educational organization behind Sesame Street, have teamed up to launch a new, national public service advertising campaign designed to encourage American children and families to practice healthy habits and to take steps to prevent the spread of the 2009 H1N1 flu virus. The PSAs featured in this campaign can be viewed on www.flu.gov.

1 Sep 2009

Stanford University starts recruiting participants for swine flu vaccine clinical trial

The Stanford University School of Medicine is recruiting participants for a clinical trial to determine the safety of an experimental vaccine against the new H1N1 strain of influenza when the vaccine is combined with an immune-stimulating substance called an adjuvant. The trial will also examine whether use of the adjuvant improves the immune response to the vaccine.

31 Aug 2009

Immunization News and Research

arGEN-X BV announces first closing of its Series A equity financing round

Polio vaccination resumes in Pakistan's Swat Valley

WHO's Chan says swine flu will 'test' world on 'fairness'

Roche Group and ImmunoCellular Therapeutics sign research agreement regarding ICT-69 antibody

E.V-Trax Employee Vaccination Tracking System helps eliminate manual data entry

First trial of 2009 H1N1 influenza vaccine testing launched

Merck's GARDASIL receives approval from FDA Advisory Committee

Maxim Health to launch its annual influenza vaccination program on October 1

Pharma manufacturer's failure to disclose endangers Swine Flu vaccination program

Taskforce formed to help speed licensure, vaccine distribution following RTS,S trials

rPA anthrax vaccine and its Valortim anthrax anti-toxin program data presented

Department of Health's guidance on swine flu vaccination leaves local health chiefs confused

H1N1 vaccine to cost countries $2.50 - $20 per dose

CDC recommends routine health examintion for all school-age children

Obama urges Americans to take precautions to protect themselves from H1N1

Members of Independence Blue Cross will receive coverage for the administration costs of the H1N1 vaccine

HAPPYBABY guide for new and expectant parents focuses on green parenting

Health care providers can register online for H1N1 influenza vaccines

Advertising campaign launched to encourage Americans practice healthy habits to prevent the spread of H1N1 flu

Stanford University starts recruiting participants for swine flu vaccine clinical trial

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News